Bloomlife combines connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. Through our connected care platform we are aggregating first of its kind longitudinal data for digital biomarker discovery to improve risk stratification.  

Bloomlife is a clinical stage women’s health company developing remote prenatal care solutions for the 20% of high risk pregnancies that drive 60% of the $110B annual US healthcare spend. We combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events Bloomlife aims to ensure every family gets a healthy start.

Bloomlife has been recognized for its revolutionary vision and potential to impact lives globally, most recently receiving innovation awards and grants from Johnson & Johnson, Fast Company World Changing Ideas, Maternal and Child Health Bureau, National Science Foundation, and the European Commission Horizon 2020 Initiative.

The Rimidi Platform is a disease management tool that allows the patient and his or her physician to effectively manage diseases together. The comprehensive solution includes remote patient monitoring and chronic care management capabilities, clinical decision support tools, disease management insights, and patient engagement tools, enabling healthcare providers to identify gaps in care management and the steps needed to close those gaps.

Rimidi combines patient-generated health data from connected devices with clinical data from EHRs to drive patient-specific clinical insights and actions via embedded clinical decision support cards. The platform integrates with glucometers, CGMs, blood pressure cuffs, scales, pulse oximeters, digital inhalers, and more.

Rimidi's platform supports disease management for the following conditions: 

• Diabetes
• Hypertension
• Heart Failure
• Obesity
• Chronic Kidney Disease
• Maternal Health, including antepartum and postpartum hypertension or diabetes
• COPD
• Asthma
• Fatty Liver

Created by clinicians, for clinicians, Rimidi is a digital health company that supports healthcare providers in the delivery of remote patient monitoring and chronic disease management with EHR-integrated software, services, and connected devices. By combining clinical data from the EHR with data from connected devices and patient surveys, Rimidi enables guideline-based management and prioritization of highest-need patients. 

Current antepartum fetal monitoring requires weekly trips to the clinic which is time consuming and inconvenient. For women in underserved communities difficulty accessing care can lead to poor adherence to screening guidelines.

By shifting antepartum fetal monitoring to the home, Bloomlife saves patients time and money, increases adherence to screening guidelines, and frees up valuable clinical resources.

Unlike the competition, Bloomlife does not require messy gels making the product experience more convenient for patients.

In the sales process, we often hear “Doesn’t Epic (or other EHR) do that?” Rimidi is not built to replace the EHR, but to enhance it by bringing in additional data sets, providing more efficient workflows, and improving the user experience. Rimidi can install and configure its platform within 3-6 weeks which is significantly faster and more cost effective than onsite EHR teams can build and support enhancements to meet clinical needs. Rimidi’s modern technology stack enables rapid cycle innovation and iteration post-go live.

Rimidi’s cardiometabolic platform is most often compared to other Remote Patient Monitoring solutions, but the platform-approach to RPM allows Rimidi to do so much more. Some key differentiators of the Rimidi platform are: (1) tight integration with leading EHRs via SMART on FHIR, (2) the breadth of the comorbid disease states we cover, (3) our incorporations of patient-reported outcomes and social determinants of health measures and (4) our Clinical Decision Support engine. Rimidi’s CDS cards support almost any insight or intervention a client wants: RPM data alerting and interventions, referral management, lab or medication recommendations, clinical trial identification, and more.